BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14635016)

  • 41. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM; Subramaniam S
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections.
    Görzer I; Kerschner H; Jaksch P; Bauer C; Seebacher G; Klepetko W; Puchhammer-Stöckl E
    J Med Virol; 2008 Aug; 80(8):1405-14. PubMed ID: 18551598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human cytomegalovirus immediate-early protein IE2-86, but not IE1-72, causes graft coronary arteriopathy in the transplanted rat heart.
    Suzuki K; Murtuza B; Suzuki N; Khan M; Kaneda Y; Yacoub MH
    Circulation; 2002 Sep; 106(12 Suppl 1):I158-62. PubMed ID: 12354726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
    Slavicek J; Puretić Z; Glavas-Boras S; Smalcelj R; Barisić I; Vuković J; Seso-Simić D; Slavicek V; Humar I; Kes P
    Acta Med Croatica; 2003; 57(1):87-90. PubMed ID: 12876872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity.
    Mousavi-Jazi M; Sundqvist VA; Linde A; Wahren B; Brytting M
    J Med Virol; 2000 Oct; 62(2):117-26. PubMed ID: 11002239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients.
    Meyer-König U; Serr A; von Laer D; Kirste G; Wolff C; Haller O; Neumann-Haefelin D; Hufert FT
    J Infect Dis; 1995 Mar; 171(3):705-9. PubMed ID: 7876623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of cytomegalovirus infection in recipients of renal transplantation].
    Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients.
    Schäfer P; Tenschert W; Cremaschi L; Schröter M; Zöllner B; Laufs R
    J Med Virol; 2001 Sep; 65(1):85-9. PubMed ID: 11505448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E; Henriot S; Zachary P; Freitag R; Fuchs A; Fritsch S; Risch S; Meyer N; Caillard S; Lioure B; Stoll-Keller F
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
    Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
    Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients.
    Renoult E; Clermont MJ; Phan V; Buteau C; Alfieri C; Tapiero B
    Pediatr Transplant; 2008 Jun; 12(4):420-5. PubMed ID: 18466427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients.
    van der Bij W; van Dijk RB; van Son WJ; Torensma R; Prenger KB; Prop J; Tegzess AM; The TH
    J Heart Transplant; 1988; 7(2):106-9. PubMed ID: 2835469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of early colonoscopy in CMV colitis of transplant recipients.
    Korkmaz M; Kunefeci G; Selcuk H; Unal H; Gur G; Yilmaz U; Arslan H; Demirhan B; Boyacioglu S; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3059-60. PubMed ID: 16213304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.